Dosage form Design for Improvement of Bioavailability of Levodopa V: Absorption and Metabolism of Levodopa in Intestinal Segments of Dogs
- 1 October 1981
- journal article
- research article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 70 (10), 1157-1160
- https://doi.org/10.1002/jps.2600701018
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Dosage form design for improvement of bioavailability of levodopa IV: Possible causes of low bioavailability of oral levodopa in dogsJournal of Pharmaceutical Sciences, 1981
- Dosage form design for improvement of bioavailability of levodopa III: Influence of dose on pharmacokinetic behavior of levodopa in dogs and parkinsonian patientsJournal of Pharmaceutical Sciences, 1980
- Dosage form Design for Improvement of Bioavailability of Levodopa II: Bioavailability of Marketed Levodopa Preparations in Dogs and Parkinsonian PatientsJournal of Pharmaceutical Sciences, 1980
- Metoclopramide, Gastric Emptying and L-Dopa AbsorptionAustralian and New Zealand Journal of Medicine, 1974
- Variability of L-Dopa Absorption in ManAustralian and New Zealand Journal of Medicine, 1974
- Absorption and Metabolism of L‐Dopa by the Human StomachEuropean Journal of Clinical Investigation, 1971
- Intestinal Absorption of Amino AcidsThe American Journal of Clinical Nutrition, 1969
- Absorption of protein digestion products: a review.Gut, 1965